These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12706813)

  • 1. Disabled-2 small interfering RNA modulates cellular adhesive function and MAPK activity during megakaryocytic differentiation of K562 cells.
    Tseng CP; Huang CL; Huang CH; Cheng JC; Stern A; Tseng CH; Chiu DT
    FEBS Lett; 2003 Apr; 541(1-3):21-7. PubMed ID: 12706813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disabled-2 is a negative regulator of integrin alpha(IIb)beta(3)-mediated fibrinogen adhesion and cell signaling.
    Huang CL; Cheng JC; Liao CH; Stern A; Hsieh JT; Wang CH; Hsu HL; Tseng CP
    J Biol Chem; 2004 Oct; 279(40):42279-89. PubMed ID: 15280374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of disabled-2 gene during megakaryocyte differentiation of k562 cells.
    Tseng CP; Huang CH; Tseng CC; Lin MH; Hsieh JT; Tseng CH
    Biochem Biophys Res Commun; 2001 Jul; 285(1):129-35. PubMed ID: 11437382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine signaling of platelet-derived growth factor regulates disabled-2 expression during megakaryocytic differentiation of K562 cells.
    Tseng CP; Chang P; Huang CL; Cheng JC; Chang SS
    FEBS Lett; 2005 Aug; 579(20):4395-401. PubMed ID: 16061224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endocytic adaptor protein Disabled-2 is required for cellular uptake of fibrinogen.
    Hung WS; Huang CL; Fan JT; Huang DY; Yeh CF; Cheng JC; Tseng CP
    Biochim Biophys Acta; 2012 Oct; 1823(10):1778-88. PubMed ID: 22705885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disabled-2 (Dab2) is required for transforming growth factor beta-induced epithelial to mesenchymal transition (EMT).
    Prunier C; Howe PH
    J Biol Chem; 2005 Apr; 280(17):17540-8. PubMed ID: 15734730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disabled-2 exerts its tumor suppressor activity by uncoupling c-Fos expression and MAP kinase activation.
    He J; Smith ER; Xu XX
    J Biol Chem; 2001 Jul; 276(29):26814-8. PubMed ID: 11359772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-arginine methyltransferase 1 suppresses megakaryocytic differentiation via modulation of the p38 MAPK pathway in K562 cells.
    Chang YI; Hua WK; Yao CL; Hwang SM; Hung YC; Kuan CJ; Leou JS; Lin WJ
    J Biol Chem; 2010 Jul; 285(27):20595-606. PubMed ID: 20442406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of nPKC-MAPK pathway in the decrease of nucleophosmin/B23 during megakaryocytic differentiation of human myelogenous leukemia K562 cells.
    Chou CC; Yung BY; Hsu CY
    Life Sci; 2007 May; 80(22):2051-9. PubMed ID: 17448503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disabled-2 is transcriptionally regulated by ICSBP and augments macrophage spreading and adhesion.
    Rosenbauer F; Kallies A; Scheller M; Knobeloch KP; Rock CO; Schwieger M; Stocking C; Horak I
    EMBO J; 2002 Feb; 21(3):211-20. PubMed ID: 11823414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for the MEK/MAPK pathway in PMA-induced cell cycle arrest: modulation of megakaryocytic differentiation of K562 cells.
    Herrera R; Hubbell S; Decker S; Petruzzelli L
    Exp Cell Res; 1998 Feb; 238(2):407-14. PubMed ID: 9473349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disabled-2 (Dab2) mediates transforming growth factor beta (TGFbeta)-stimulated fibronectin synthesis through TGFbeta-activated kinase 1 and activation of the JNK pathway.
    Hocevar BA; Prunier C; Howe PH
    J Biol Chem; 2005 Jul; 280(27):25920-7. PubMed ID: 15894542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct effects of Disabled-2 on transferrin uptake in different cell types and culture conditions.
    Chu HC; Tseng WL; Lee HY; Cheng JC; Chang SS; Yung BY; Tseng CP
    Cell Biol Int; 2014 Nov; 38(11):1252-9. PubMed ID: 24889971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a novel negative regulator (DOC-2/DAB2) of c-Src in normal prostatic epithelium and cancer.
    Zhou J; Scholes J; Hsieh JT
    J Biol Chem; 2003 Feb; 278(9):6936-41. PubMed ID: 12473651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained activation of MEK1-ERK1/2 pathway in membrane skeleton occurs dependently on cell adhesion in megakaryocytic differentiation.
    Mizutani C; Tohyama Y; Miura Y; Hishita T; Nishihara T; Yamamura H; Ichiyama S; Uchiyama T; Tohyama K
    Biochem Biophys Res Commun; 2002 Sep; 297(3):664-71. PubMed ID: 12270146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disabled-2 mediates c-Fos suppression and the cell growth regulatory activity of retinoic acid in embryonic carcinoma cells.
    Smith ER; Capo-chichi CD; He J; Smedberg JL; Yang DH; Prowse AH; Godwin AK; Hamilton TC; Xu XX
    J Biol Chem; 2001 Dec; 276(50):47303-10. PubMed ID: 11577091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphogenesis of human endothelial cells is inhibited by DAB2 via Src.
    Orlandini M; Nucciotti S; Galvagni F; Bardelli M; Rocchigiani M; Petraglia F; Oliviero S
    FEBS Lett; 2008 Jul; 582(17):2542-8. PubMed ID: 18582465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disabled-2 is a novel alphaIIb-integrin-binding protein that negatively regulates platelet-fibrinogen interactions and platelet aggregation.
    Huang CL; Cheng JC; Stern A; Hsieh JT; Liao CH; Tseng CP
    J Cell Sci; 2006 Nov; 119(Pt 21):4420-30. PubMed ID: 17074833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways.
    Gu J; Tamura M; Yamada KM
    J Cell Biol; 1998 Nov; 143(5):1375-83. PubMed ID: 9832564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane type sialidase inhibits the megakaryocytic differentiation of human leukemia K562 cells.
    Jin UH; Ha KT; Kim KW; Chang YC; Lee YC; Ko JH; Kim CH
    Biochim Biophys Acta; 2008 May; 1780(5):757-63. PubMed ID: 18339327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.